Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Inositol and In Vitro Fertilization with Embryo Transfer.

Simi G, Genazzani AR, Obino ME, Papini F, Pinelli S, Cela V, Artini PG.

Int J Endocrinol. 2017;2017:5469409. doi: 10.1155/2017/5469409. Epub 2017 Feb 28. Review. Erratum in: Int J Endocrinol. 2019 Apr 11;2019:8309405.

2.

Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature.

Regidor PA, Schindler AE, Lesoine B, Druckman R.

Horm Mol Biol Clin Investig. 2018 Mar 2;34(2). pii: /j/hmbci.2018.34.issue-2/hmbci-2017-0067/hmbci-2017-0067.xml. doi: 10.1515/hmbci-2017-0067. Review.

PMID:
29498933
3.

Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.

Papaleo E, Unfer V, Baillargeon JP, Fusi F, Occhi F, De Santis L.

Fertil Steril. 2009 May;91(5):1750-4. doi: 10.1016/j.fertnstert.2008.01.088. Epub 2008 May 7.

PMID:
18462730
4.
5.

Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET.

Zheng X, Lin D, Zhang Y, Lin Y, Song J, Li S, Sun Y.

Medicine (Baltimore). 2017 Dec;96(49):e8842. doi: 10.1097/MD.0000000000008842. Review.

6.

Effect of myo-inositol and alpha-lipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: a pilot study.

Rago R, Marcucci I, Leto G, Caponecchia L, Salacone P, Bonanni P, Fiori C, Sorrenti G, Sebastianelli A.

J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4):913-23.

PMID:
26753656
8.
9.

Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome.

Pacchiarotti A, Carlomagno G, Antonini G, Pacchiarotti A.

Gynecol Endocrinol. 2016;32(1):69-73. doi: 10.3109/09513590.2015.1101444. Epub 2015 Oct 28.

PMID:
26507336
12.

Slow oocyte freezing and thawing in couples with no sperm or an insufficient number of sperm on the day of in vitro fertilization.

Virant-Klun I, Bacer-Kermavner L, Tomazevic T, Vrtacnik-Bokal E.

Reprod Biol Endocrinol. 2011 Feb 2;9:19. doi: 10.1186/1477-7827-9-19.

14.

[Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].

Ye H, Huang GN, Cao YX, Zhong Y, Huang YH, Zhu GJ, Zhou LM, Chen ZJ, Shi JZ, Zeng Y, Weng N, Huang XF, Yang J, Zhu YM, Li YP, Yi D, Zhuang GL.

Zhonghua Fu Chan Ke Za Zhi. 2013 Nov;48(11):838-42. Chinese.

PMID:
24444561
15.
16.

Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.

Qin N, Chen Q, Hong Q, Cai R, Gao H, Wang Y, Sun L, Zhang S, Guo H, Fu Y, Ai A, Tian H, Lyu Q, Daya S, Kuang Y.

Fertil Steril. 2016 Aug;106(2):334-341.e1. doi: 10.1016/j.fertnstert.2016.04.006. Epub 2016 Apr 22.

PMID:
27114329
17.

A pre-in vitro maturation medium containing cumulus oocyte complex ligand-receptor signaling molecules maintains meiotic arrest, supports the cumulus oocyte complex and improves oocyte developmental competence.

Santiquet NW, Greene AF, Becker J, Barfield JP, Schoolcraft WB, Krisher RL.

Mol Hum Reprod. 2017 Sep 1;23(9):594-606. doi: 10.1093/molehr/gax032.

PMID:
28586460
18.
19.

Supplemental Content

Support Center